Kangfuyan capsule combined with antibiotics for pelvic inflammatory diseases:a Meta-analysis
- Author:
Li HUANG
1
;
Shao-bin WEI
;
Mei LUO
1
;
Sai ZHANG
1
;
Mao-ya LI
1
Author Information
- Publication Type:Journal Article
- Keywords: pelvic inflammatory disease; Kangfuyan capsule; Meta-analysis
- From: Chinese Journal of Practical Gynecology and Obstetrics 2019;35(04):455-461
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To evaluate the efficacy and safety of Kangfuyan capsule combined with antibiotics in the treatment of pelvic inflammatory diseases.METHODS: The CNKI,WANFANG,VIP,CBM,Pubmed,Embase and The Cochrane Library were searched from their date of foundation to August 1,2018.The randomized controlled trial were included on the treatment for pelvic inflammatory diseases by Kangfuyan capsules with antibiotics or by antibiotics alone.Meta-analysis was conducted using RevMan5.3 software.RESULTS: Totally 20 reports(2820 subjects)were included.The clinal of cure rate,pain relief,pelvic signs relief,pelvic effusion reduction,decrease in recurrence rate had statistical difference between two groups(P<0.05).There was no significant difference in adverse reaction rate or the effect in reducing pelvic mass(P>0.05).CONCLUSION: Kangfuyan capsule combined with antibiotics in treating pelvic inflammatory disease can improve clinical efficacy,reduce the occurrence of sequelae of pelvic inflammatory disease,without increasing adverse reactions.A large quantity of samples and long-term clinical studies need to be conducted to confirm the effects.
